v3.26.1
Collaboration, License and Option Agreements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 36 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2021
Dec. 31, 2025
Nov. 30, 2025
Nov. 18, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Collaboration Amendment Date     2019-04      
Liability to licensor $ 19,806     $ 19,806    
BeiGene            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Collaboration Amendment Date     2021-11      
Upfront Non-Refundable Payment     $ 25,000      
Revenues 0 $ 0        
Current portion of deferred revenue           $ 19,800
Liability to licensor 19,800     $ 19,800    
Context Therapeutics Inc            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Revenues 0 $ 0        
Maximum Potential Aggregate Payments $ 133,500          
Milestone payment received         $ 2,000